Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

about

[Tegafur gimeracil oteracil potassium capsule induced acute interstitial lung disease: a case report].

P2860

Q53083981-C8572CFF-7C40-4F97-872D-4E5ABA140616

P2860

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

Item

http://www.wikidata.org/entity/Q38133562

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

@en

type

Item

label

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

@en

prefLabel

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

@en

P1476

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

@en

P2093

Koji Takeda

http://www.w3.org/2001/XMLSchema#string

P2860

Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer

Erlotinib in previously treated non-small-cell lung cancer

Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505.

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.

Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study.

P304

301-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834013500702

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23997830

http://www.w3.org/2001/XMLSchema#string

P932

3752178

http://www.w3.org/2001/XMLSchema#string

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

about

P2860

P2860

Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932